Bariatric Surgery

Both sleeve gastrectomy and Roux-en-Y gastric bypass support weight loss and improvement in obesity-related comorbidities. Reducing insulin through surgery can benefit diabetic patients because chronically elevated insulin is a core driver of type 2 diabetes. Postoperative mental health after bariatric surgery is shaped by multiple interacting factors rather than weight loss alone. Bariatric surgery alters the small intestine to reduce GIP production, thereby lowering overall insulin secretion. Surgically reducing stomach size compromises general mineral absorption because stomach acid and surface area are both critical for mineral uptake. Bariatric surgery permanently reduces the digestive system's absorptive surface area, creating a structural barrier to meeting nutritional requirements. The study examined depressive and anxiety symptoms after bariatric surgery and compared sleeve gastrectomy with Roux-en-Y gastric bypass. Bariatric surgery is presented as a standard treatment for severe obesity when conservative weight loss methods fail.